7267de96__Companies___Flagship_Ventures__Status
[Description] Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. [Initial Date] 2013 [4] View Profile [Status] 
Private
A c q u i r e d
P u b l i c
P r i v a t e
All Companies | Flagship Ventures
Status